169 related articles for article (PubMed ID: 31139214)
1. The Clinical Effect of Oral Vitamin D2 Supplementation on Psoriasis: A Double-Blind, Randomized, Placebo-Controlled Study.
Disphanurat W; Viarasilpa W; Chakkavittumrong P; Pongcharoen P
Dermatol Res Pract; 2019; 2019():5237642. PubMed ID: 31139214
[TBL] [Abstract][Full Text] [Related]
2. Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial.
Jenssen M; Furberg AS; Jorde R; Wilsgaard T; Danielsen K
JAMA Dermatol; 2023 May; 159(5):518-525. PubMed ID: 36988936
[TBL] [Abstract][Full Text] [Related]
3. Oral vitamin D
Ingram MA; Jones MB; Stonehouse W; Jarrett P; Scragg R; Mugridge O; von Hurst PR
J Dermatolog Treat; 2018 Nov; 29(7):648-657. PubMed ID: 29480035
[TBL] [Abstract][Full Text] [Related]
4. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of the effect of monthly vitamin D supplementation in mild psoriasis
Jarrett P; Camargo CA; Coomarasamy C; Scragg R
J Dermatolog Treat; 2018 Jun; 29(4):324-328. PubMed ID: 28849682
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
Blauvelt A; Leonardi CL; Gooderham M; Papp KA; Philipp S; Wu JJ; Igarashi A; Flack M; Geng Z; Wu T; Camez A; Williams D; Langley RG
JAMA Dermatol; 2020 Jun; 156(6):649-658. PubMed ID: 32267471
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials.
Theodoridis X; Grammatikopoulou MG; Stamouli EM; Talimtzi P; Pagkalidou E; Zafiriou E; Haidich AB; Bogdanos DP
Nutrition; 2021 Feb; 82():111024. PubMed ID: 33183899
[TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial.
Suebthawinkul C; Panyakhamlerd K; Yotnuengnit P; Suwan A; Chaiyasit N; Taechakraichana N
Climacteric; 2018 Oct; 21(5):491-497. PubMed ID: 30095022
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplementation for sickle cell disease.
Soe HH; Abas AB; Than NN; Ni H; Singh J; Said AR; Osunkwo I
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010858. PubMed ID: 28105733
[TBL] [Abstract][Full Text] [Related]
11. Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial.
Roth DE; Al Mahmud A; Raqib R; Akhtar E; Perumal N; Pezzack B; Baqui AH
Nutr J; 2013 Apr; 12():47. PubMed ID: 23587190
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis.
Papp KA; Menter MA; Raman M; Disch D; Schlichting DE; Gaich C; Macias W; Zhang X; Janes JM
Br J Dermatol; 2016 Jun; 174(6):1266-76. PubMed ID: 26800231
[TBL] [Abstract][Full Text] [Related]
13. Effect of multivitamin on serum 25-hydroxy vitamin D level in postmenopausal women: A randomized, double-blind, placebo-controlled trial.
Khrutmuang D; Panyakhamlerd K; Chatkittisilpa S; Jaisamrarn U; Taechakraichana N
Osteoporos Sarcopenia; 2016 Jun; 2(2):89-93. PubMed ID: 30775472
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis.
Formisano E; Proietti E; Borgarelli C; Pisciotta L
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571324
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of narrowband ultraviolet B phototherapy and levels of serum vitamin D3 in psoriasis: A prospective study.
Gupta A; Arora TC; Jindal A; Bhadoria AS
Indian Dermatol Online J; 2016; 7(2):87-92. PubMed ID: 27057487
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Papp KA; Langley RG; Lebwohl M; Krueger GG; Szapary P; Yeilding N; Guzzo C; Hsu MC; Wang Y; Li S; Dooley LT; Reich K;
Lancet; 2008 May; 371(9625):1675-84. PubMed ID: 18486740
[TBL] [Abstract][Full Text] [Related]
17. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
[TBL] [Abstract][Full Text] [Related]
18. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Daily Supplementation of Milk Fortified With Vitamin D2 for Three Months in Healthy School Children: A Randomized Placebo Controlled Trial.
Marwaha RK; Dabas A; Puri S; Kalaivani M; Dabas V; Yadav S; Dang A; Pullakhandam R; Gupta S; Narang A
Indian Pediatr; 2021 Sep; 58(9):820-825. PubMed ID: 34302325
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial.
Reich K; Armstrong AW; Foley P; Song M; Wasfi Y; Randazzo B; Li S; Shen YK; Gordon KB
J Am Acad Dermatol; 2017 Mar; 76(3):418-431. PubMed ID: 28057361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
